InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the complete record of transactions filed by YOUNG JAMES F, Director. Officer active across 1 companies, notably NOVAVAX INC. Aggregated, 8 disclosures have been published. Total volume traded: €592k. The latest transaction was disclosed on 31 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
1,400 shares
Common Stock
SEC:0001209191-22-038597:0·
€592,0608,945 shares@ €66.18890.040% mcap77.7% of flow
Common Stock
SEC:0001209191-22-022544:0·
€84,7683,750 shares@ €22.60480.0057% mcap100.0% of flow
Common Stock
SEC:0001209191-22-000955·
€84,7683,750 shares@ €22.60480.0057% mcap11.1% of flow
Common Stock
SEC:0001209191-22-000955:0·
10,000 shares
Common Stock
SEC:0001209191-21-045561·
10,000 shares
Common Stock
SEC:0001209191-21-045561:0·
7,590 shares
Common Stock
SEC:0001209191-21-043695·
7,590 shares
Common Stock
SEC:0001209191-21-043695:0·
8 of 8 declarations
About YOUNG JAMES F
James F. Young is a Board Member at Novavax Inc. In this role, he contributes to the governance of the company by bringing his expertise in the biopharmaceutical sector. James plays a key role in evaluating the company's performance and overseeing growth strategies. His industry experience is a valuable asset to Novavax's management team.
